Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN)

56 filings reported holding VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2024.
Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 14,613,555 shares of 31,887,528 outstanding shares and own 46% of the company stock.
Largest 10 shareholders include BVF INC/IL (2,000,000 shares), GREAT POINT PARTNERS LLC (1,858,735 shares), STEMPOINT CAPITAL LP (1,848,582 shares), VANGUARD GROUP INC (1,793,166 shares), COMMODORE CAPITAL LP (1,575,000 shares), Nantahala Capital Management, LLC (1,517,696 shares), SPHERA FUNDS MANAGEMENT LTD. (808,550 shares), CITADEL ADVISORS LLC (743,920 shares), ARMISTICE CAPITAL, LLC (364,000 shares), and BlackRock Inc. (348,438 shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.